Cardiff Oncology Inc. sell Global_Player
Start price
31.08.20
/
50%
€6.70
Target price
03.09.20
€6.00
Performance (%)
-11.94%
End price
03.09.20
€5.90
Summary
This prediction ended on 03.09.20 with a price of €5.90. The prediction for Cardiff Oncology Inc. closed with a convincing performance of -11.94%. Global_Player has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Cardiff Oncology Inc. | -0.240% | -0.240% | 58.295% | -62.857% |
iShares Core DAX® | 1.395% | -0.272% | 17.642% | 15.576% |
iShares Nasdaq 100 | 2.287% | 6.912% | 37.651% | 51.525% |
iShares Nikkei 225® | 1.617% | 3.038% | 12.910% | 8.243% |
iShares S&P 500 | 0.659% | 3.687% | 29.434% | 44.236% |
According to Global_Player what are the pros and cons of Cardiff Oncology Inc. for the foreseeable future?
Pros
Cons
Risky Investment
Comments by Global_Player for this prediction
In the thread Trovagene diskutieren
Sell mit Kursziel 6,0
In the thread Trading Trovagene
Sell beendet
Stopped prediction by Global_Player for Cardiff Oncology Inc.
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€3.73
25.04.24
25.04.24
-
25.04.25
25.04.25
0.80%
27.04.24
27.04.24
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.24
17.11.22
17.11.22
-
17.11.23
17.11.23
0.48%
26.12.22
26.12.22
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.65
18.09.22
18.09.22
-
18.09.23
18.09.23
-3.77%
01.10.22
01.10.22
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€6.00
17.01.22
17.01.22
-
17.01.23
17.01.23
-44.67%
22.01.22
22.01.22
Risky Investment